Retrospective, descriptive, multicenter study with chart review on cefiderocol in the treatment of patients with Acinetobacter spp infections. resistant to carbapenems. ARES
REST OF EEOO WITH MEDICATIONS
Clinical trial information
- Promoter: SHIONOGI BV
- Execution start: 31/03/2022
- End of execution: 30/04/2022
- PI: CARMEN HIDALGO TENORIO